Press release
Thyroid Cancer Drugs Market Size 2032 | Suzhou Zelgen Biopharmaceuticals, Jiangsu Chia-Tai Tianqing Pharmaceutical, Takeda, Bristol-Myers Squibb, Genentech, AffyImmune Therapeutics, Inc., Taizhou Hanzhong biomedical co. LTD, NantCell, Bayer, Merck Sharp &
Thyroid Cancer Market
To know in detail about the Thyroid Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, click here; Thyroid Cancer Market Forecast- https://www.delveinsight.com/sample-request/thyroid-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Some of the key facts of the Thyroid Cancer Market Report:
• The Thyroid Cancer market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• According to Surveillance, Epidemiology and End Results (SEER), there will be 43,800 new cases of thyroid cancer in the US in 2022
• According to a study by The American Cancer Society, there will likely be 43,800 new instances of thyroid cancer in the United States in 2022, with 11,860 of those cases affecting males and 31,940 affecting women
• Thyroid cancer new cases per 100,000 men and women annually were 15.7. The annual mortality rate was 0.5 per 100,000 men and women. These statistics are based on deaths from 2014 to 2018 and are age-adjusted (National Cancer Institute, 2020)
• The leading Thyroid Cancer Companies such as Novartis, AffyImmune Therapeutics, Eli Lilly + LoxoOncology, AstraZeneca, Celgene Corporation, Bayer, Hutchison Medipharma, GlaxoSmithKline, Eisai Pharma, Sanofi, Pfizer, CSPC ZhongQi Pharma, Gilead Sciences, Eli Lilly and Company, Merck Sharp & Dohme LLC, Genentech, Inc., Exelixis, and others
• Promising Thyroid Cancer Therapies such as Dabrafenib+Trametinib: , AIC 100, LOXO-260, Durvalumaband tremelimumab, Lenalidomide, Sorafenib (Nexavar,BAY43-9006), Surufatinib, Continuous pazopanib, Lenvatinib, Vandetanib, AG-013736, LBH58, HA121-28 tablets, TF2 and 68 Ga-IMP-288, Selpercatinib, Pembrolizumab (Keytruda), Vemurafenib, XL184, and others.
Get a Free sample for the Thyroid Cancer Treatment Market Size Report @ https://www.delveinsight.com/sample-request/thyroid-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Thyroid Cancer Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
• Total Prevalence of Thyroid Cancer
• Prevalent Cases of Thyroid Cancer by severity
• Gender-specific Prevalence of Thyroid Cancer
• Diagnosed Cases of Episodic and Chronic Thyroid Cancer
Download the report to understand which factors are driving Thyroid Cancer epidemiology trends @ Thyroid Cancer Epidemiology Forecast- https://www.delveinsight.com/sample-request/thyroid-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Thyroid Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Thyroid Cancer market or expected to get launched during the study period. The analysis covers Thyroid Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
Thyroid Cancer Therapies and Companies
• Dabrafenib+Trametinib: Novartis
• AIC 100: AffyImmune Therapeutics
• LOXO-260: Eli Lilly + LoxoOncology
• Durvalumaband tremelimumab: AstraZeneca
• Lenalidomide: Celgene Corporation
• Sorafenib (Nexavar,BAY43-9006): Bayer
• Surufatinib: Hutchison Medipharma
• Continuous pazopanib: GlaxoSmithKline
• Lenvatinib: Eisai Pharma
• Vandetanib: Sanofi
• AG-013736: Pfizer
• LBH589: Novartis
• HA121-28 tablets: CSPC ZhongQi Pharma
• TF2 and 68 Ga-IMP-288: Gilead Sciences
• Selpercatinib: Eli Lilly and Company
• Pembrolizumab (Keytruda): Merck Sharp & Dohme LLC
• Vemurafenib: Genentech, Inc.
• XL184: Exelixis
Discover more about therapies set to grab major Thyroid Cancer market share @ Thyroid Cancer Treatment Market- https://www.delveinsight.com/sample-request/thyroid-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Thyroid Cancer Market Strengths
• There are a lot of approved therapies for the thyroid cancer which is a major market mover.
• The incidence rate of thyroid cancer has increased in the past which has lead to higher patient pool.
Thyroid Cancer Market Opportunities
• With the increasing global population, the incidence of thyroid cancer has also surged, leading to increased opportunities for research and development
Scope of the Thyroid Cancer Market Report
• Study Period: 2019-2032
• Coverage: 7MM
• Thyroid Cancer Companies: Novartis, AffyImmune Therapeutics, Eli Lilly + LoxoOncology, AstraZeneca, Celgene Corporation, Bayer, Hutchison Medipharma, GlaxoSmithKline, Eisai Pharma, Sanofi, Pfizer, CSPC ZhongQi Pharma, Gilead Sciences, Eli Lilly and Company, Merck Sharp & Dohme LLC, Genentech, Inc., Exelixis, and others
• Thyroid Cancer Therapies: Dabrafenib+Trametinib: , AIC 100, LOXO-260, Durvalumaband tremelimumab, Lenalidomide, Sorafenib (Nexavar,BAY43-9006), Surufatinib, Continuous pazopanib, Lenvatinib, Vandetanib, AG-013736, LBH58, HA121-28 tablets, TF2 and 68 Ga-IMP-288, Selpercatinib, Pembrolizumab (Keytruda), Vemurafenib, XL184, and others
• Thyroid Cancer Therapeutic Assessment: Thyroid Cancer current marketed and Thyroid Cancer emerging therapies
To know more about Thyroid Cancer companies working in the treatment market, visit @ Thyroid Cancer Clinical Trials and Therapeutic Assessment- https://www.delveinsight.com/sample-request/thyroid-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Thyroid Cancer Market Report Introduction
2. Executive Summary for Thyroid Cancer
3. SWOT analysis of Thyroid Cancer
4. Thyroid Cancer Patient Share (%) Overview at a Glance
5. Thyroid Cancer Market Overview at a Glance
6. Thyroid Cancer Disease Background and Overview
7. Thyroid Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Thyroid Cancer
9. Thyroid Cancer Current Treatment and Medical Practices
10. Thyroid Cancer Unmet Needs
11. Thyroid Cancer Emerging Therapies
12. Thyroid Cancer Market Outlook
13. Country-Wise Thyroid Cancer Market Analysis (2019-2032)
14. Thyroid Cancer Market Access and Reimbursement of Therapies
15. Thyroid Cancer Market Drivers
16. Thyroid Cancer Market Barriers
17. Thyroid Cancer Appendix
18. Thyroid Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Cancer Drugs Market Size 2032 | Suzhou Zelgen Biopharmaceuticals, Jiangsu Chia-Tai Tianqing Pharmaceutical, Takeda, Bristol-Myers Squibb, Genentech, AffyImmune Therapeutics, Inc., Taizhou Hanzhong biomedical co. LTD, NantCell, Bayer, Merck Sharp & here
News-ID: 3604574 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
